Tailored Strategies Based on Sales Data
Plans to Expand Personalized Experiences, Including a Fitting System That Takes Body Type and Seating Habits Into Account
[E-Daily Reporter Hyera Lee ] DUOBACK CO., LTD. announced on the 15th that it is strengthening its customer-tailored strategy by expanding the availability of mesh headrests across its major chair product lines. DUOBACK CO., LTD. products. (Photo courtesy of DUOBACK CO., LTD.) DUOBACK CO., LTD.(073190)The company plans to sequentially introduce mesh headrest options for the Q1, SOAM, and DX series, depending on the model and sales channel. This strategy reflects actual consumer preference data, and the company plans to continue expanding personalized options tailored to users’ environments and tastes in the future. DUOBACK CO., LTD. explained that it confirmed consumer preference through its recent “Bravo Edge” Wadiz crowdfunding campaign, where the mesh headrest option accounted for approximately 68% of all selections. The mesh headrest is characterized by its use of highly breathable mesh material, which provides a comfortable seating experience even during extended use. As situations requiring prolonged sitting—such as remote work and online learning—become more common, demand is growing, particularly among consumers who prioritize breathability and seating comfort. Reflecting the growing demand in the chair market for personalized products tailored to body types and usage environments, DUOBACK CO., LTD. is incorporating ergonomic technology and consumer data into its product development. Going forward, the company plans to expand its range of customized solutions, such as fitting systems that take into account each user’s body type and sitting habits. DUOBACK CO., LTD. spokesperson stated, “The expanded use of mesh headrests is the result of incorporating actual consumer choice data into our sales strategy,” adding, “We will continue to strengthen our product competitiveness and personalized options by reflecting consumer demand and market changes.”
SK Eco Plant and KCC Corporation(002380)achieved a successful public offering of corporate bonds, drawing a favorable response in the bookbuilding process despite significant uncertainty caused by a s…
As medical technology advances, the treatment of human diseases is evolving toward “personalized” and “precision medicine.” Consequently, demand for personalized treatment and precision medicine is no…
On July 23, the domestic stock market surged as expectations for artificial intelligence (AI) investments combined with strong momentum in healthcare and biotechnology stocks. The tech-heavy KOSDAQ ma…